BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:U.S. DOD CDMRP - Pancreatic Cancer Research Program
DTSTART;VALUE=DATE:20220708
DTSTAMP:20260509T062256Z
UID:1caa078b68c17709e9af228b9c7e81b6c420fee043b88167b05d4dc7
CATEGORIES:Call for proposal
DESCRIPTION:Through the Congressionally Directed Medical Research Program 
 (CDMRP)\, the Department of Defense is announcing the Pancreatic Cancer Re
 search Program (PCARP) Awards. Two award programs are available:\n\n	The F
 Y22 Idea Development Award supports the development of innovative\, high-r
 isk/high reward research that could lead to critical discoveries or major 
 advancements that will accelerate progress in improving outcomes for indiv
 iduals with pancreatic cancer. This award mechanism is designed to support
  innovative ideas with the potential to yield impactful data and new avenu
 es of investigation and offers a partnering PI option for early-career inv
 estigators.\n	 \n	The FY22 Translational Research Partnership Award suppo
 rts partnerships between clinicians and research scientists that will acce
 lerate the movement of promising ideas in pancreatic cancer toward clinica
 l applications. This award supports the development of translational resea
 rch collaborations between two independent investigators to address a cent
 ral problem or question in pancreatic cancer in a manner that would be les
 s readily achievable through separate efforts. One partner in the collabor
 ation must function as a research scientist and the other partner as a cli
 nician investigator.  It should be clear that both have had equal intelle
 ctual input in the design of the research project.  Projects involving co
 nvergence science partnerships are strongly encouraged.  At least one par
 tner must have expertise in either pancreatic cancer research or pancreati
 c cancer patient care.  Inclusion of experts from outside the pancreatic 
 cancer field is encouraged. Note that full support for large-scale clinica
 l trials is not expected within this FOA\; however\, small pilot clinical 
 trials are allowed.\n\n\nDEADLINE:\n\n\n	FY22 Idea Development Award - Pre
 -Application (2 to 3 pages limit): July 8\, 2022\, submission on Oct. 6\, 
 2022\n	 \n	FY22 Translational Research Partnership Award - Pre-Applicatio
 n (two-page limit for the narrative part plus biosketch and reference): Ju
 ly 8\, 2022\, submission on Oct. 6\, 2022\n\n\nFUNDING:\n\n\n	FY22 Idea De
 velopment Award - Anticipated direct costs will not exceed $500\,000 - $65
 0’000 for a maximum of 3 years period of performance\n	 \n	FY22 Transla
 tional Research Partnership Award - Anticipated direct costs will not exce
 ed $750\,000 for 3 years period of performance\n\n\nELIGIBILITY: EPFL rese
 archers are eligible to participate.\n\nHOW TO APPLY: Pre-applications are
  submitted through the eBRAP platform. Full applications will be made via 
 a Grants.gov workspace. Full application packages can be downloaded from G
 rants.gov at any time.\n\nFOR FURTHER INFORMATION: Please refer to the FOA
 s below and feel free to contact the Research Office for any question or a
 ny help.\n\n\n	FY22 Idea Development Award - W81XWH-22-PCARP-IDA\n	 \n	FY
 22 Investigator-Initiated Research Award - W81XWH-22-PCARP-TRPA\n\n\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR